AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19

NCT04507256 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

COMBINATION_PRODUCT: AZD7442
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]